miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume 63, Issue 1, Pages 124-136
Publisher
Springer Science and Business Media LLC
Online
2019-10-29
DOI
10.1007/s00125-019-05026-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA expression profile in plasma from type 1 diabetic patients: Case-control study and bioinformatic analysis
- (2018) Taís S. Assmann et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Fatty acid metabolism in CD8+ T cell memory: Challenging current concepts
- (2018) Brenda Raud et al. IMMUNOLOGICAL REVIEWS
- Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes
- (2018) Linda Åkerman et al. PLoS One
- Non-Invasive Multiphoton Imaging of Islets Transplanted Into the Pinna of the NOD Mouse Ear Reveals the Immediate Effect of Anti-CD3 Treatment in Autoimmune Diabetes
- (2018) Robert A. Benson et al. Frontiers in Immunology
- miR-143 Regulates Memory T Cell Differentiation by Reprogramming T Cell Metabolism
- (2018) Tengfei Zhang et al. JOURNAL OF IMMUNOLOGY
- Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis
- (2018) Ana Luisa Perdigoto et al. DIABETOLOGIA
- MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling
- (2018) Xiaomei Liu et al. GLIA
- Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells
- (2017) Katharina Essig et al. IMMUNITY
- Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacity
- (2017) Maja Wallberg et al. IMMUNOLOGY
- Levels of MicroRNA Heterogeneity in Cancer Biology
- (2017) Nina Petrovic et al. Molecular Diagnosis & Therapy
- miR-150-Mediated Foxo1 Regulation Programs CD8 + T Cell Differentiation
- (2017) Young Ho Ban et al. Cell Reports
- Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?
- (2017) G. Sebastiani et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes
- (2017) Marta Garcia-Contreras et al. Scientific Reports
- Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus
- (2016) Nasim Samandari et al. DIABETOLOGIA
- Distribution of microRNA biomarker candidates in solid tissues and body fluids
- (2016) Tobias Fehlmann et al. RNA Biology
- Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study
- (2016) Attila A. Seyhan et al. Scientific Reports
- Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes
- (2015) Simke Demeester et al. DIABETES CARE
- Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2β, and GAD65
- (2015) Liron Abuhatzira et al. FASEB JOURNAL
- Population dynamics of islet-infiltrating cells in autoimmune diabetes
- (2015) Angela M. Magnuson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune Diabetes
- (2015) Giuliana Ventriglia et al. Biomed Research International
- The emerging role of circulating microRNAs as biomarkers in autoimmune diseases
- (2014) Li Zeng et al. AUTOIMMUNITY
- The complexity of miRNA-mediated repression
- (2014) A Wilczynska et al. CELL DEATH AND DIFFERENTIATION
- Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis Reverses Diabetes in Recent-Onset NOD Mice
- (2014) S. Robert et al. DIABETES
- Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
- (2014) Sefina Arif et al. DIABETES
- Diabetes-Associated MicroRNAs in Pediatric Patients With Type 1 Diabetes Mellitus: A Cross-Sectional Cohort Study
- (2014) Julia Osipova et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients 1型糖尿病患者外周血单个核细胞miR-146表达下调与胰岛持续免疫失衡相关
- (2014) Minglan Yang et al. Journal of Diabetes
- Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets
- (2014) Feng Wang et al. Frontiers of Medicine
- CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data
- (2013) Gabriela Bindea et al. BIOINFORMATICS
- Circulating microRNAs as novel biomarkers for diabetes mellitus
- (2013) Claudiane Guay et al. Nature Reviews Endocrinology
- Comprehensive microRNA Analysis Identifies miR-24 and miR-125a-5p as Plasma Biomarkers for Rheumatoid Arthritis
- (2013) Koichi Murata et al. PLoS One
- MicroRNA biogenesis: regulating the regulators
- (2012) Emily F. Finnegan et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Low doses of anti-CD3, ciclosporin A and the vitamin D analogue, TX527, synergise to delay recurrence of autoimmune diabetes in an islet-transplanted NOD mouse model of diabetes
- (2012) F. Baeke et al. DIABETOLOGIA
- Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression
- (2012) Lotte B. Nielsen et al. Experimental Diabetes Research
- Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
- (2012) Tatiana Takiishi et al. JOURNAL OF CLINICAL INVESTIGATION
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
- (2012) Ken T. Coppieters et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Analytical challenges and technical limitations in assessing circulating MiRNAs
- (2012) Manuel Mayr et al. THROMBOSIS AND HAEMOSTASIS
- Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus
- (2012) Honglei Wang et al. Translational Research
- Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b
- (2011) Riccardo L Rossi et al. NATURE IMMUNOLOGY
- Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
- (2010) Nobuyoshi Kosaka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serum and Urinary Cell-free MiR-146a and MiR-155 in Patients with Systemic Lupus Erythematosus
- (2010) G. WANG et al. JOURNAL OF RHEUMATOLOGY
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes
- (2009) Chris Wallace et al. NATURE GENETICS
- Analysis of islet inflammation in human type 1 diabetes
- (2008) A. Willcox et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started